Plasmodium falciparum founder populations in western Cambodia have reduced artemisinin sensitivity in vitro

Antimicrob Agents Chemother. 2014 Aug;58(8):4935-7. doi: 10.1128/AAC.03055-14. Epub 2014 May 27.

Abstract

Reduced Plasmodium falciparum sensitivity to short-course artemisinin (ART) monotherapy manifests as a long parasite clearance half-life. We recently defined three parasite founder populations with long half-lives in Pursat, western Cambodia, where reduced ART sensitivity is prevalent. Using the ring-stage survival assay, we show that these founder populations have reduced ART sensitivity in vitro at the early ring stage of parasite development and that a genetically admixed population contains subsets of parasites with normal or reduced ART sensitivity.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alleles
  • Antimalarials / pharmacology*
  • Artemisinins / pharmacology*
  • Cambodia / epidemiology
  • Drug Resistance / genetics*
  • Founder Effect
  • Half-Life
  • Humans
  • Life Cycle Stages / drug effects*
  • Life Cycle Stages / genetics
  • Malaria, Falciparum / drug therapy
  • Malaria, Falciparum / epidemiology
  • Malaria, Falciparum / parasitology
  • Mutation
  • Parasitic Sensitivity Tests
  • Plasmodium falciparum / drug effects*
  • Plasmodium falciparum / genetics
  • Plasmodium falciparum / growth & development

Substances

  • Antimalarials
  • Artemisinins
  • artemisinin